PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1420293
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1420293
The global body contouring devices market is poised for substantial growth in the coming years, with a projected compound annual growth rate (CAGR) of 18% from 2024 to 2031. In 2024, the market was valued at US$ 1.6 Billion. Body contouring devices encompass both invasive and non-invasive or minimally invasive techniques aimed at reshaping and sculpting various areas of the body, enhancing overall aesthetics and achieving firmness.
The primary driver of this burgeoning market is the escalating prevalence of obesity worldwide, primarily due to unhealthy lifestyles. According to the World Health Organization (WHO), obesity has become a global epidemic, tripling since 1975, with approximately 30% of the world's population now classified as obese. Sedentary lifestyles, often associated with increased urbanization, have further contributed to the global rise in obesity.
Improved safety and efficacy of body contouring techniques have led to increased life expectancy, spurring demand for these procedures. Major companies are also investing in initiatives such as mergers and acquisitions, novel product launches, and partnerships, further propelling market growth.
The onset of the COVID-19 pandemic significantly impacted the aesthetic market, including the body contouring segment. Initially, all aesthetic procedures, both invasive and non-invasive, experienced a decline in demand. However, as the pandemic progressed, there was a resurgence in interest and demand for body contouring procedures, surpassing pre-pandemic levels by 2021, as reported by The International Society of Aesthetic Plastic Surgery.
North America, accounting for 35.6% of the global market in 2021, continues to dominate the body contouring devices market. Factors contributing to this dominance include a growing geriatric population, robust medical infrastructure, well-established reimbursement policies, and the presence of key market players. Additionally, the region's culture of acceptance and openness toward body contouring treatments and an appearance-conscious customer pool are propelling the non-invasive body contouring market.
Meanwhile, the Asia-Pacific (APAC) region is poised to experience the highest CAGR of 15.2% over the forecast period. Countries such as China, Japan, and India, known for their well-developed healthcare infrastructure and facilities, are increasingly focusing on research and development activities. These nations have also been longstanding hubs for aesthetic procedures.
United States: The U.S. market for body contouring devices benefits from its advanced healthcare infrastructure and extensive research activities. Government support, coupled with a high prevalence of obesity cases, is expected to drive market growth in the country.
China: Rising awareness of chronic diseases, a growing senescent population, and increased healthcare expenditure are the driving forces behind the body contouring devices market's expansion in China. Cost-effective and high-quality treatments, along with a surge in disposable income and an aging population, contribute to market growth.
Major players in the body contouring devices market are investing in research and development to expedite the development of new devices, gaining a competitive edge. Expansion of production capacities and strategic partnerships and collaborations among key players are expected to further bolster market growth.
The global body contouring devices market is on a trajectory of remarkable growth, fueled by evolving consumer preferences, increasing awareness of health-related issues, and continuous advancements in medical aesthetics. As demand for body contouring procedures continues to rise, the market's potential for expansion remains substantial.